About this Research Topic
Smart nanocarriers are revolutionizing the landscape of cancer treatment by significantly enhancing the efficacy of therapeutic interventions. These advanced delivery systems are engineered to overcome the limitations of traditional chemotherapy, such as nonspecific distribution and systemic toxicity. They can be designed to target cancer cells with high precision, utilizing ligands that recognize and bind to specific tumor markers. This targeted approach ensures that the therapeutic agents are released directly at the tumor site, maximizing their efficacy while minimizing damage to healthy tissues.
Additionally, smart nanocarriers can be tailored to respond to the unique microenvironment of tumors, such as pH or enzymatic activity, triggering the release of drugs only in the presence of cancerous cells. This level of specificity not only improves the therapeutic index of anticancer drugs but also reduces adverse side effects, enhancing the overall patient experience.
Innovations in nanotechnology have also enabled the incorporation of multiple therapeutic agents within a single carrier, allowing for combination therapy that can target various pathways of cancer cell survival and proliferation simultaneously. Furthermore, the use of biocompatible and biodegradable materials in constructing these nanocarriers ensures their safety and reduces the risk of long-term toxicity.
Ongoing research and clinical trials are continually refining these technologies, promising a future where smart nanocarriers could become a cornerstone of personalized cancer therapy. Therefore, this Research Topic aims to provide a comprehensive, contemporary collection of research focusing on exploring smart nanocarriers for cancer treatment. We welcome Original Research Articles, Reviews, Mini-Reviews, Systematic Reviews, Perspectives, Commentaries, Data notes, and technical notes, but are not limited to the following:
• Investigate the development of novel ligands and targeting moieties to enhance the specificity of nanocarriers for various cancer cell types.
• Explore the use of tumor-specific stimuli, such as pH, enzymes, and temperature, to develop smart nanocarriers.
• Improve techniques for real-time imaging and tracking of nanocarriers within the body
• Assess the long-term biocompatibility and biodegradability of materials used in nanocarrier construction.
Additionally, smart nanocarriers can be tailored to respond to the unique microenvironment of tumors, such as pH or enzymatic activity, triggering the release of drugs only in the presence of cancerous cells. This level of specificity not only improves the therapeutic index of anticancer drugs but also reduces adverse side effects, enhancing the overall patient experience.
Innovations in nanotechnology have also enabled the incorporation of multiple therapeutic agents within a single carrier, allowing for combination therapy that can target various pathways of cancer cell survival and proliferation simultaneously. Furthermore, the use of biocompatible and biodegradable materials in constructing these nanocarriers ensures their safety and reduces the risk of long-term toxicity.
Ongoing research and clinical trials are continually refining these technologies, promising a future where smart nanocarriers could become a cornerstone of personalized cancer therapy. Therefore, this Research Topic aims to provide a comprehensive, contemporary collection of research focusing on exploring smart nanocarriers for cancer treatment. We welcome Original Research Articles, Reviews, Mini-Reviews, Systematic Reviews, Perspectives, Commentaries, Data notes, and technical notes, but are not limited to the following:
• Investigate the development of novel ligands and targeting moieties to enhance the specificity of nanocarriers for various cancer cell types.
• Explore the use of tumor-specific stimuli, such as pH, enzymes, and temperature, to develop smart nanocarriers.
• Improve techniques for real-time imaging and tracking of nanocarriers within the body
• Assess the long-term biocompatibility and biodegradability of materials used in nanocarrier construction.
Keywords: Nanocarriers, Cancer, Tumor-Specific Stimuli, Anti-cancer
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
